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Abstract: Although meal replacement can lead to weight reduction, there is uncertainty whether this
dietary approach implemented into a lifestyle programme can improve long-term dietary intake.
In this subanalysis of the Almased Concept against Overweight and Obesity and Related Health Risk
(ACOORH) study (n = 463), participants with metabolic risk factors were randomly assigned to
either a meal replacement-based lifestyle intervention group (INT) or a lifestyle intervention control
group (CON). This subanalysis relies only on data of participants (n = 119) who returned correctly
completed dietary records at baseline, and after 12 and 52 weeks. Both groups were not matched for
nutrient composition at baseline. These data were further stratified by sex and also associated with
weight change. INT showed a higher increase in protein intake related to the daily energy intake
after 12 weeks (+6.37% [4.69; 8.04] vs. +2.48% [0.73; 4.23], p < 0.001) of intervention compared to
CON. Fat and carbohydrate intake related to the daily energy intake were more strongly reduced in
the INT compared to CON (both p < 0.01). After sex stratification, particularly INT-women increased
their total protein intake after 12 (INT: +12.7 g vs. CON: −5.1 g, p = 0.021) and 52 weeks (INT: +5.7 g
vs. CON: −16.4 g, p = 0.002) compared to CON. Protein intake was negatively associated with
weight change (r = −0.421; p < 0.001) after 12 weeks. The results indicate that a protein-rich dietary
strategy with a meal replacement can improve long-term nutritional intake, and was associated with
weight loss.
Keywords: protein-rich diet; meal replacement; nutritional reports; weight loss
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1. Introduction
Lifestyle interventions comprising of exercise and healthy eating have been shown to
result in clinically relevant effects regarding body composition and metabolic risk factors [1].
However, long-term adherence to these measures remains low overall [2]. In this context,
meal replacement therapies with partial [3,4] or complete replacements, also known as
very low energy diets [5], have been shown to be effective and appropriate for patients
with obesity and related comorbidities. This therapy approach leads to improved markers
of cardiometabolic risk factors, as recently documented by the ACOORH study group [6,7].
Furthermore, considering the benefits of meal replacements for the treatment of obesity and
its comorbidities [3,5–7], this dietary strategy has been officially included as a treatment
option for type 2 diabetes [8] as well as overweight and obesity [9]. Moreover, meal
replacement strategies appear to be a convenient lifestyle solution (e.g., can be individually
composed and used for “to-go” meals) for patients to use, which has been shown to drive
greater results and at least comparable compliance compared to conventional lifestyle
approaches [10,11]. Especially in regard to type 2 diabetes, there is a wealth of data
showing clinically relevant effects in terms of remission rates [5] as well as weight reduction
and improvement of glucose and insulin levels [1,2,4,12–14]. Despite these findings, there
remains a general controversy about weight maintenance and the long-term effectiveness of
weight management programmes [15]. However, recent findings from the 2-years follow-
up of the DiRECT-study indicate that structured weight management programs with
incorporated formula diets can lead to long-term benefits regarding weight maintenance
and medication reduction [16,17].
Aside from the meal replacement approach, there are indications that a protein-rich
diet also contributes to weight loss and maintenance [18,19]. For example, the landmark
study of Larsen et al. particularly demonstrated that a modest increase in the protein
content together with a modest reduction in the glycaemic index of the diet can lead to an
improvement in and maintenance of weight loss [20]. However, there remains a lack of
individual long-term data from dietary records of randomized controlled interventions
with meal replacement showing that meal replacement strategies are able not only to lead
to a reduced short-term energy intake but also to improve long-term nutritional intake with
an accompanied weight reduction. Therefore, the present subanalysis of the ACOORH
trial investigates the influence of a weight management invention in combination with
a protein-rich and low-glycaemic meal replacement on changes in dietary intake and
accompanied weight changes in participants with overweight or obesity and accompanied
metabolic risk factors.
2. Materials and Methods
2.1. Study Design and Participants
This subanalysis was part of the international, multicentre randomized controlled
ACOORH trial (n = 463) [6] in participants with overweight and obesity (BMI 27–35 kg/m2)
and accompanied metabolic risk factors. The present study was a behavioural study imple-
menting health education and lifestyle interventions by dietary intervention and physical
activity. Eligible participants were randomly assigned with a 2:1 allocation ratio to either
a meal replacement-based lifestyle intervention group (INT) or a lifestyle intervention
control group (CON). The lifestyle intervention was characterised by an initial intense
12-week intervention phase. This period was followed by a moderately intense intervention
phase until week 26 and a further follow-up phase after 52 weeks. In contrast to the total
ACOORH sample, in this subanalysis, only data from subjects (n = 119) who completed all
assessments at baseline, weeks 12, and 52 were included (Figure 1). Participating centres
and duration of recruitment was described in detail elsewhere [6,7]. The ACOORH trial
was executed in accordance with the ethical standards laid down in the 1964 Declaration of
Helsinki and its later amendments, and the research protocol was approved by different
ethics committees in each country. The study was registered at drks.de under the num-
ber DRKS00006811. All participating individuals gave written informed consent before
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entering the study. Inclusion and exclusion criteria were described in detail elsewhere [7].
Participants visited the study centres at baseline as well as after 12, 26, and 52 weeks of
follow-up. Detailed information of the study design and visits can be found elsewhere [6].
Figure 1. Study flow chart. CON-group, lifestyle intervention control group; INT-group, meal replacement-based lifestyle
intervention group; PP, per-protocol analysis.
2.2. Intervention and Monitoring
Participants in both groups (CON, INT) received quarterly guideline booklets contain-
ing information on general healthy eating advice (limit sugar consumption; eat 3 meals/day;
give preference to whole-grain foods, fruits and vegetables; limit fat and alcohol intake). In
addition, participants were given advice on how to increase their daily levels of physical
activity and were provided with telemonitoring devices (pedometers and scales; detailed
information can be found elsewhere [7]) automatically transferring recorded data into a
personalized online portal. Moreover, individuals of both groups were advised to complete
a 4-day unweighed food record (2x weekend days and 2x weekdays) at baseline, as well
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as at the 12- and 52-weeks follow-up. The evaluation of the food records was carried
out using the EBISpro nutrition system (Stuttgart, Germany) [21]. In addition, partici-
pants were instructed to record their leisure time physical activity (LTPA) via a validated
questionnaire [22] at baseline, as well as at the 12- and 52-weeks follow-up.
Additionally, participants assigned to the INT group were asked to consume a meal
replacement (a commercially available high-protein, soy-yogurt-honey product (Almased-
Vitalkost®; Almased-Wellness-GmbH, Bienenbüttel, Germany)) during the first 26-week
intervention phase (which has already been described in detail elsewhere [6]), and received
an accompanying instruction manual. The meal replacement was characterised by a protein
content of 53.3% (83% soy-protein-isolate and 17% skimmed milk yoghurt) and a very low
glycaemic index (GI = 27), equivalent to 1507 kJ (360 kcal) energy per 100 g powder [23,24].
The accompanying manual provided information about meal replacement preparation as
well as general facts about low-carbohydrate meals. However, this information (particularly
about low-carbohydrate nutrition) was also part of the study visits and consultations, as
well as the content of the quarterly guideline booklets for both groups. Individuals of the
INT group were advised to note down the amount of meal replacement consumed, the
number of meals replaced, and their current weight and waist circumference into their
personal journal. After the 26-weeks follow-up, INT group participants were advised
to manage their weight reduction by individual lifestyle changes but not encouraged
to further replace their meals continuously until week 52. However, participants were
allowed to replace meals when their weight reduction was compromised by events such
as celebrations or vacations. At each study visit, nurses and dietitians reviewed the
quarterly guideline booklets and provided dietary education and lifestyle counselling to
the participants in both groups.
2.3. Statistical Analyses
The method as well as the assumptions of the sample size calculation for the ACOORH
study have been described in detail elsewhere [7]. Data of the current subanalysis were
presented as the means and standard deviations (mean ± SD), means and 95% confidence
intervals (mean [95% CI]), or percentages, as appropriate. As applied in previous ACOORH
publications [6,7], non-parametric data were analysed with Mann–Whitney U, Wilcoxon,
or Friedman tests and parametric data with Student’s t-test, paired t-test, or analysis of
variance with repeated measures to determine any differences between and within groups
following the intervention. Differences in changes after 12 as well as 52 weeks between
both groups were analysed using ANCOVAs adjusting for baseline values. In addition,
linear regression analyses were performed to examine the associations of dietary intake
and weight change after 12 and 52 weeks of intervention. Dichotomous variables, as well
as frequencies, were compared by Fisher’s exact test. A per-protocol approach (completer
analysis including only participants with a complete set of data) was applied in the present
study. All statistical tests were two-sided, and the level of significance was set at α = 0.05.
All analyses were performed using the SAS System®, version 9.4, under the Windows
operating system. The statistical analysis was performed by an independent and external
institute not involved in the study execution (ACOMED statistik®, Leipzig, Germany).
3. Results
From the initial cohort (n = 463), 68% (317/463) of the participants completed the
study. Furthermore, posteriori performed data evaluation revealed that 38% (119/317) and
33% (104/317) of the study completers provided correctly completed dietary records after
12 and 52 weeks of intervention. The anthropometrical, clinical and dietary characteristics
of the study participants are illustrated in Table 1. Baseline characteristics of the group
with incomplete dietary records showed no differences compared to the group with cor-
rectly filled out food diaries (Supplementary Materials Table S1). INT (n = 82) or CON
(n = 37) completers with correctly filled out dietary records were not significantly different
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regarding their anthropometrical and clinical characteristics, as well as dietary intake even
when stratified by sex (all p > 0.05).
Table 1. Baseline characteristics of participants with correctly filled out dietary records for INT and
CON stratified by sex.
Anthropometrical and
Clinical Parameters
INT-Group (n = 82)
[Men (n = 32)
Women (n = 50)]
CON-Group (n = 37)
[Men (n = 13)
Women (n = 24)]
Sex (%) 39.0 35.1
Age (years) 52 ± 8 52 ± 8
Weight (kg) 92.8 ± 10.1 92.2 ± 10.4
BMI (kg/m2) 31.6 ± 2.4 30.8 ± 2.4
WC (cm) 107 ± 7 106 ± 8
WHR 0.97 ± 0.06 0.96 ± 0.06
FM (kg) 36.0 ± 6.0 36.3 ± 6.1
FFM (kg) 57.0 ± 5.5 55.7 ± 6.6
HbA1c (%) 5.49 ± 0.33 5.45 ± 0.29
FBG (mg/dl) 92 ± 10 92 ± 11
SBP (mmHg) 135 ± 15 134 ± 17
DBP (mmHg) 92 ± 11 91 ± 8
Total cholesterol (mg/dl) 213 ± 36 218 ± 51
HDL-C (mg/dl) 53 ± 14 55 ± 10
LDL-C (mg/dl) 137 ± 31 136 ± 43
Triglycerides (mg/dl) 140 ± 73 164 ± 73
Shown are means ± standard deviations, or percentages. BMI, body mass index; DBP, diastolic blood pressure;
FBI, fasting blood insulin; FBG, fasting blood glucose; FFM, fat free mass; FM, fat mass; HDL-C, HDL cholesterol;
HOMA-Index, homeostasis model assessment-index; LDL-C, LDL cholesterol; SBP, systolic blood pressure; WC,
waist circumference; WHR, waist-to-hip ratio.
Table 2 shows the complete case analyses for the intra- and intergroup changes in
the INT and CON subgroups after 12 and 52 weeks compared to baseline for partici-
pants with correctly completed food records. Overall, the INT group showed a signifi-
cantly higher increase in protein intake (in relation to the daily energy intake) after 12
(+6.37% [95% CI: 4.69; 8.04] vs. +2.48% [95% CI: 0.73; 4.23], p < 0.001) and 52 weeks (+2.86%
[95% CI: 1.40; 4.32] vs. +1.45% [0.04; 2.86], p = 0.052 (borderline)) of intervention, compared
to the CON group. This trend was underlined by a covariance analysis with a repeated
measurement analysis from baseline over 12 weeks until week 52 (p < 0.001).
Fat intake (−3.08% [95% CI: −4.82; −1.34] vs. +1.08% [95% CI: −1.23; 3.39], p = 0.006)
as well as carbohydrate intake (−3.22% [95% CCI: −4.82; −1.63] vs. −3.27% [−5.52; −1.02],
p = 0.008) in relation to the daily energy intake were significantly stronger reduced in
the INT group compared to CON after 12 weeks of intervention but lost significance
after 52 weeks of follow-up. Intake of component variables of carbohydrates (i.e., glucose,
fructose) was also significantly more reduced in the INT group in comparison to CON (all
p < 0.001).
After stratifying by sex, female participants of the INT group significantly increased
their total protein intake after 12 (INT: +12.7 g vs. CON: −5.1 g, p = 0.021) and 52 weeks (INT:
+5.7 g vs. CON: −16.4 g, p = 0.002) compared to female CON participants (Supplementary
Materials Table S2).
In contrast to fat and carbohydrate intake (both r= 0.373; p < 0.01), univariate linear
regression analyses revealed that protein intake was inversely associated with both weight
change (r= −0.421) and energy intake (r= −0.243) (Figure 2) after 12 weeks in the whole
cohort (INT + CON) (both p < 0.01). These associations lost significance after 52 weeks of
follow-up.
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Table 2. Intra and intergroup changes of dietary intake data in the INT and CON group after 12 and 52 weeks of intervention (complete case analysis).
Complete Case
Analysis Baseline 12 Weeks p 52 Weeks p
INT CON INT CON (INT vs. CON) INT CON (INT vs. CON)
Energy (kcal) 2129 ± 580 2208 ± 587 −372 [−556; −174] *** −288 [−625; 55] * 0.112 −217 [−440; 8.80] * −493 [−809; −154] *** 0.389
Protein (g) 91 ± 21 92 ± 24 9.10 [1.05; 18.6] * 1.40 [−13.8; 14.9] 0.680 5.72 [−2.35; 13.2] −16.4 [−26.0; −2.31] * 0.075
Protein (proportion of
daily energy intake (%)) 18.3 ± 5.5 17.4 ± 3.2 6.37 [4.69; 8.04] *** 2.48 [0.73; 4.23] ** <0.001 2.86 [1.40; 4.32] *** 1.45 [0.04; 2.86] 0.052
Fat (g) 90.1 ± 30.2 94.2 ± 29.2 −20.7 [−30.9; −10.1] *** −9.72 [−28.3; 8.64] 0.051 −13.5 [−23.6; −3.02] ** −24.3 [−38.7; −6.91] ** 0.509
Fat (proportion of daily
energy intake (%)) 40.0 ± 6.5 39.4 ± 6.1 −3.08 [−4.82; −1.34] *** 1.08 [−1.23; 3.39] 0.006 −2.11 [−3.87; −0.36] * −0.65 [−3.21; 1.91] 0.424




38.9 ± 7.5 40.4 ± 7.4 −3.22 [−4.82; −1.63] *** −3.27 [−5.52; −1.02] ** 0.008 −1.24 [−3.06; 0.57] −1.27 [−4.16; 1.63] 0.362
Glucose (g) 10.6 ± 6.6 12.8 ± 8.3 −3.23 [−4.54; −1.93] *** −2.34 [−5.37; 0.68] <0.001 −1.29 [−3.00; 0.42] * −3.10 [−6.57; 0.37] * 0.981
Fructose (g) 13.0 ± 8.3 17.1 ± 12.8 −3.46 [−5.21; −1.71] *** −3.51 [−8.15; 1.12] <0.001 −0.92 [−3.21; 1.38] −4.41 [−9.54; 0.72] 0.969
Sucrose (g) 36.2 ± 21.2 39.8 ± 21.0 −13.7 [−18.8; −8.60] *** −11.9 [−19.5; −4.25] ** 0.144 −9.58 [−15.2; −4.01] ** −15.2 [−22.5; −7.87] *** 0.814
Alcohol (g) 16.3 ± 17.1 15.3 ± 18.7 −2.38 [−6.74; 2.32] −1.21 [−9.89; 7.11] 0.614 0.07 [−5.92; 6.02] −0.82 [−8.91; 7.94] 0.663
Alcohol (proportion of
daily energy intake (%)) 4.62 ± 6.03 4.56 ± 5.75 −0.24 [−1.13; 0.65] −0.11 [−1.60; 1.38] 0.884 0.29 [−0.98; 1.56] 0.28 [−1.24; 1.79] 0.861
Dietary fibre (g) 17.4 ± 7.4 20.2 ± 7.2 −2.37 [−3.69; −1.04] *** −0.68 [−2.84; 1.47] 0.008 0.24 [−1.62; 2.10] −2.60 [−4.77; −0.43] * 0.171
Weight (kg) 92.8 ± 10.1 92.2 ± 10.4 −7.23 [−8.37; −6.13] *** −4.84 [−6.35; −3.22] *** 0.008 −5.27 [−6.82; −3.81] *** −4.45 [−7.01; −1.91] * 0.469
Data are shown as mean [95% CI] or mean ± SD. Within-group changes after 12 and 52 weeks were analysed using Wilcoxon Test (in case of normal distribution using paired t-Test). *** p < 0.001 vs. baseline;
** p < 0.01 vs. baseline; * p < 0.05 vs. baseline. Differences in changes after 12 as well as 52 weeks between both groups were analyzed using ANCOVAs adjusting for baseline values and partly for the interaction
term ‘group × baseline value’. Week 12: (INT: n = 82 [Men (n = 32) Women (n = 50)]), (CON: n = 37 [Men (n = 13) Women (n = 24)]); Week 52: (INT: n = 72 [Men (n = 29) Women (n = 43)], (CON: n = 32 [Men
(n = 11) Women (n = 21)]).
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Figure 2. Association of protein intake (% of daily energy intake) of the whole cohort (INT + CON) (change from baseline to
12 weeks of intervention) with (A) energy and (B) weight change.
Neither FM nor FFM was associated with protein, carbohydrate or fat intake in both
groups at any study visit. LTPA significantly increased within the first 12 weeks in both
groups but showed no significant difference in the intergroup analysis at any time point
and did also not associate with weight change or dietary intake.
4. Discussion
In the first 12 weeks of the present study, meal replacement effectively led to a reduced
daily energy intake by limiting fat and carbohydrate consumption. However, protein intake
was not affected by a reduction in energy intake. Indeed, although total energy intake
was reduced (particularly in the first 12 weeks), protein intake, both absolute as well as
relative to the daily energy intake, increased. Univariate regression analyses showed that
this protein increase was inversely associated with weight change in the whole cohort after
12 weeks of intervention. These findings, therefore, indicate that it is possible to modify the
dietary intake of participants with a high metabolic risk profile using a meal-replacement,
in order to achieve a recommended protein intake for optimal health outcome, whilst
at the same time being in negative energy imbalance [25,26]. The results also showed
that a lifestyle intervention comprised of a meal replacement can be more effective than
conventional dietary advice to increase protein intake. These results are in line with other
comparable studies demonstrating that a lifestyle intervention with an accompanying meal
replacement strategy can lead to weight loss as well as an increase in protein intake in older
adults with obesity after 6 months of intervention [27] or to an improved overall dietary
adequacy after 12 months in middle-aged women [28].
Based on the experience of the DIOGenes project [20], there is emerging scientific
evidence that a diet with moderately high protein content and possibly a low glycaemic
index is a precondition for weight-loss maintenance. This dietary approach has been
confirmed via a wealth of data obtained from randomized clinical trials [11,18,19,29–33].
The findings support the recommendation for a high-protein or protein-supplemented
Nutrients 2021, 13, 376 8 of 11
diet for different population groups to maintain fat-free mass as well as improve body
composition and metabolic biomarkers [25,34,35]. This may be of importance for many
individuals, including not only participants in weight-loss programmes, but also for older
adults and for normal-weight subjects and athletes who do not consume optimal dietary
protein levels on a daily basis. Furthermore, especially postmenopausal women can
benefit from meal replacement regimes as these products are composed of ingredients
such as calcium and vitamin D supporting bone health and supplementation of necessary
minerals [36,37]. However, pre-treatment macronutrient intake does not seem to correlate
with weight outcomes following a 1-year lifestyle intervention [38].
Although weight change was beneficially associated with protein intake, neither FM
nor FFM was associated with protein, carbohydrate or fat intake in both groups at any time
point. These findings are confirmative to the current literature showing a reduction of FM
and FFM [6] as a typical result of a lifestyle intervention weight loss program [39].
Besides possible beneficial effects due to the composition of the meal replacement or
the change in nutritional intake, there could also be an influence of the meal replacement
regime on the nutrition behaviour. This behaviour change is maybe caused as a part of a
strategy to compensate for overeating and maintain dietary goals [40]. However, after the
initial 26-weeks intervention phase, INT group participants were advised to manage their
weight reduction by individual lifestyle changes but were not encouraged to further replace
meals continuously until week 52. Participants were allowed to replace meals when their
weight reduction was compromised by events such as celebrations or vacations though.
In addition, the specific mechanism(s) of action of the soy-yoghurt-honey meal-
replacement product used in the present study, as well as its biological compounds such as
isoflavones, soy-proteins, bio-active peptides and honey oligosaccharides, have to be con-
sidered for their influence on dietary behaviour, especially in terms of appetite regulation
and energy intake [23,41–45].
The strengths of the present study comprise a relatively large number of participants
with a detailed analysis of their dietary intakes. Furthermore, all diet diaries were evaluated
by a single academic nutritionist, thus eliminating inter-assessor variations and errors.
There are, however, limitations in the present study that should be considered. In
addition to the fundamental limitation of self-reported dietary records [46,47], an addi-
tional disadvantage of the present subanalysis is that the diet diaries were available in
the intended form for only 119 of the 463 study participants. Besides missing data due
to dropouts, the primary reasons for the loss of dietary intake data were uncompleted,
incorrect, or not standardised reports. However, baseline characteristics of the completer
group with correctly filled diet diaries were not different compared to the whole ACOORH
cohort and, therefore, this subgroup can be assumed to be a representative sample. More-
over, based on the extent of missing data, an intention-to-treat approach was not possible
to apply.
The primary intention of the intervention was to investigate the short-term (12 weeks)
and long-term (52 weeks) effects of this lifestyle strategy approach on dietary intake. Thus,
we did not collect dietary data after 26 weeks. Furthermore, the CON-group did not receive
a control or energy-adjusted product. Moreover, the higher completer rate in the INT group
compared to CON can be possibly explained by the higher success of the INT group.
To prevent overestimating of the beneficial effects of protein intake in this study,
it must be taken into account that only less than 6% of the energy intake change was
explained by the increase of daily protein intake in the whole group. However, weight
change showed a significant (p < 0.001) and relevant (R2 ≈ 0.18) association with the
daily protein intake. Therefore, the macronutrient composition has a minor but significant
effect in this intervention program and indicates that macronutrient composition can be a
contributing factor in a lifestyle intervention.
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5. Conclusions
The present results of this subanalysis from the ACOORH weight management study
indicate that a protein-rich and low-glycaemic meal replacement incorporated into a
lifestyle intervention can improve dietary intake by increasing protein intake and decreas-
ing fat and carbohydrate intake and can lead to successful weight loss.
Supplementary Materials: The following are available online at https://www.mdpi.com/2072-664
3/13/2/376/s1, Table S1: Baseline characteristics for ACOORH completers and participants with
correctly filled dietary records after 12 weeks, Table S2: Intra and intergroup changes of dietary intake
data in the INT and CON group after 12 and 52 weeks of intervention stratified by sex (complete
case analysis).
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